Mitral Valve Replacement

5

Review clinical trials related to Mitral Valve Replacement. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Abbott Cephea Mitral Valve Disease Registry

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Abbott Medical DevicesUpdated: Jun 22, 2026Locations: 23Duration: 2 Years
Eligibility criteria

Symptomatic mitral valve disease resulting in mitral regurgitation and/or severe... [+4]

Prior surgical or interventional treatment that interferes with the Cephea valve... [+4]

Status: Recruiting

Replacement of the Native Mitral Valve Using the ReValve System

This study is to collect preliminary chronic information on performance and safety of the ReValve System.

Participants needed: 25
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: ReValve Solutions Inc.Updated: May 22, 2026Locations: 2
Eligibility criteria

Symptomatic functional and/or degenerative MR (≥2+) due to ischemic and non-isch... [+4]

Untreated clinically significant coronary artery disease requiring revasculariza... [+7]

Status: Not yet recruiting

CardioLogical Interventions and Acute strOke Treatment sTudy

The study aims to investigate characteristics and prognosis of ischemic stroke cases following cardiological interventions, focusing on the effectiveness and safety of acute ischemic stroke treatments.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of L'AquilaUpdated: Jan 7, 2026Locations: 1Duration: 180 Days
Eligibility criteria

acute ischemic stroke in adult patient (18 years of age or older) as diagnosed a... [+3]

Stroke-like symptoms due primarily to another non-ischemic/hemorrhagic acute neu... [+2]

Status: Recruiting

MITRIS China Post Market Clinical Follow-up (PMCF) Study

Collect clinical outcomes on acute and long-term safety and performance of the MITRIS RESILIA Mitral Valve, Model 11400M, in subjects requiring replacement of their native or prosthetic mitral valve with or without concomitant procedures.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Edwards LifesciencesUpdated: Dec 30, 2025Locations: 13
Eligibility criteria

18 years or older at the time of informed consent [+3]

Active endocarditis 3 months prior to the procedure [+4]

Status: Not yet recruiting

Outcomes of Complete Versus Partial Preservation of the Sub-valvular Apparatus in Cases of Mitral Valve Replacement

The purpose of this study is to evaluate the outcomes of complete (preservation of both anterior and posterior leaflets) versus partial (preservation of posterior leaflet only) preservation of subvalvular apparatus in cases of mitral valve replacement

Participants needed: 80
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Assiut UniversityUpdated: Feb 6, 2025Locations: 1
Eligibility criteria

- Age between 18 and 60 years [+2]

- Patients who have undergone previous mitral valve surgery or other heart surge... [+3]